查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997201

離心式血液幫浦市場：按幫浦類型、流量、材質、應用和最終用戶分類－2026-2032年全球市場預測

Centrifugal Blood Pumps Market by Pump Type, Flow Rate, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，離心式血液幫浦市場價值將達到 9,302 萬美元，到 2026 年將成長至 1.0427 億美元，到 2032 年將達到 1.5646 億美元，年複合成長率為 7.71%。

主要市場統計數據
基準年 2025 9302萬美元
預計年份：2026年 1.0427億美元
預測年份 2032 1.5646億美元
複合年成長率 (%) 7.71%

簡要概述了影響離心式血液幫浦採購決策的核心技術、臨床作用和性能特徵。

離心式血泵集血流動力學支持、緊湊的面積以及與先進體外循環系統的兼容性於一體，已成為急性心臟護理各個環節中不可或缺的組成部分。本文闡述了現代離心式血泵設計的技術基礎，重點在於流體動態、磁浮和機械軸承結構，並說明了這些技術如何影響血流特性、血液相容性和設備耐久性。此外，本文還概述了這些血液泵發揮關鍵作用的臨床應用，包括心臟手術術前術後支持、長期體外膜氧合（ECMO）治療以及短期至長期心室輔助裝置（VAD）。

更嚴格的法規、臨床需求和快速的技術進步如何重塑離心式血液幫浦的開發、商業化和臨床應用。

離心式血液幫浦領域正經歷一場變革，其促進因素包括臨床實務、監管和技術創新。臨床上，患者群體老化以及機械循環和體外循環支持適應症的不斷擴大，推動了對兼顧療效和安全性的器械的需求。同時，監管機構正在加強上市後監管和器械檢驗要求，迫使製造商加強對耐久性測試、血液相容性測試和真實世界臨床數據項目的投入。這些監管變化正在加速從傳統機械軸承設計到磁浮和先進流體動態系統的轉變，從而顯著降低血液損傷和維護負擔。

2025 年的關稅環境將迫使供應鏈重組，供應商本地化，並籌資策略，以確保臨床的連續性和成本的穩定性。

2025年實施的新關稅措施使醫療設備相關人員的跨境供應鏈和籌資策略變得更加複雜，對依賴國際採購零件和成品的公司影響尤為顯著。關稅調整提高了進口特殊金屬、精密軸承和聚合物化合物等原料的製造商的成本基礎，加速了供應商關係和成本工程方法的重新評估。為此，一些製造商正在加快供應商認證計劃，盡可能實現生產本地化，並重組物流系統，以最大限度地減少關稅對最終用戶的影響。

整合細分智慧，識別臨床適應症、最終用戶概況、泵浦技術、流量模式和材料選擇交叉的領域，從而確定採購優先事項。

細分市場層面的洞察揭示了臨床需求與技術能力最緊密交匯的點。對特定應用趨勢的評估表明，心臟外科手術、體外膜氧合（ECMO）和心室瓣膜支撐裝置是三個不同的需求領域。 ECMO 又細分為體外二氧化碳清除、靜脈-動脈 ECMO 和靜脈-靜脈 ECMO，每種 ECMO 對流量和耐久性都有其獨特的需求。心室瓣膜支撐裝置分為雙心室、左心室和右心室支撐配置，每種配置都需要相應的控制策略和軸承技術。

美洲、歐洲、中東和非洲以及亞太地區的區域部署模式、還款狀況和供應鏈趨勢都會影響設備的採用。

區域趨勢正在影響整個離心式血泵市場的採用模式、報銷機制和供應鏈韌性。在美洲，先進的三級醫療機構和專科心臟病醫院在完善的報銷機制和緊密的臨床網路的支持下，推動了離心式血泵的早期臨床應用，這些機制和網路促進了技術的傳播。這些機構發揮創新中心的作用，產生真實世界數據和治療通訊協定，並透過區域轉診系統進行推廣。同時，在小規模的醫院和門診中心，成本控制壓力和集中採購機制正在影響設備的選擇。

競爭趨勢著重於臨床證據服務網路和技術合作，這使得現有製造商、專業公司和顛覆性參與企業。

競爭格局由成熟的醫療設備製造商、專業製造商以及專注於差異化泵浦架構和服務模式的新興技術參與企業組成。市場領導強調提供臨床證據、建立廣泛的服務網路，並為灌注師和手術團隊提供全面培訓計畫。中型企業則傾向於工程柔軟性和上市速度競爭，利用模組化設計和高度適應性的控制系統來滿足特定的臨床需求。

為製造商、供應商和買家提供切實可行的策略行動，以改善臨床結果、確保供應彈性並建立靈活的商業性方法。

產業領導者應優先致力於改善臨床療效，同時穩定供應和成本結構。首先，他們應投資於強力的臨床證據項目，量化血液相容性、設備耐用性和以患者為中心的療效，尤其是在心臟手術、體外膜肺氧合（ECMO）亞型和心室輔助裝置（VAD）配置等關鍵應用領域。已證實的臨床獲益仍是協調部署和報銷方案的最有力論點。其次，他們應加強供應商多元化和近岸外包策略，以減輕關稅對成本波動的影響，同時確保關鍵金屬和聚合物零件的品質。

為了支持我們的結論，我們採用了一種透明的混合方法研究框架，該框架結合了對臨床相關人員的初步訪談、技術評估和供應鏈分析。

本研究整合了多種證據來源，以提供穩健的分析基礎。主要資料收集包括對不同醫院環境和區域市場的臨床醫生、體外循環技師、採購負責人和製造工程師進行結構化訪談。這些訪談提供了對臨床工作流程、設備整合挑戰和服務需求的定性評估。次要研究著重於同儕審查的血液相容性文獻、監管指導文件、軸承技術和材料科學方面的技術白皮書以及產品特定的技術規範，以檢驗性能聲明。

摘要重點闡述了臨床有效性、供應彈性和卓越服務之間的相互作用，這些因素決定了醫療設備的長期部署。

總之，離心式血泵正處於臨床需求與技術創新交會的十字路口。儘管現代設計趨勢傾向於優先考慮血液相容性、高反應控制系統以及降低整個生命週期的負擔，但監管和關稅壓力正迫使製造商重新思考其供應鏈和循證策略。從門診手術中心到三級醫院，終端使用者需要能夠適應當地臨床工作流程、人員配備和整體營運需求的解決方案，因此，服務能力和培訓與設備性能同等重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 離心式血液幫浦市場：依幫浦類型分類

  • 流體軸承
  • 磁浮
  • 機械軸承

第9章 依流量分類的離心式血液幫浦市場

  • 高流速
  • 低流量
  • 中等流速

第10章 離心式血液幫浦市場：依材料分類

  • 金屬
  • 聚合物

第11章 離心式血液幫浦市場：依應用領域分類

  • 心臟外科手術
  • 體外膜氧合（ECMO）
    • 外部二氧化碳移除
    • 靜脈-動脈體外膜氧合（ECMO）
    • 靜脈-靜脈體外膜氧合（ECMO）
  • 心室輔助裝置
    • 雙心室輔助裝置
    • 左心室輔助裝置
    • 右心室輔助裝置

第12章 離心式血液幫浦市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 心臟醫療中心
    • 綜合醫院
    • 三級醫療醫院
  • 研究機構

第13章 離心式血液幫浦市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 離心式血泵市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 離心式血液幫浦市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國離心式血液幫浦市場

第17章：中國離心式血液幫浦市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Artimedica
  • Baxter International Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • Eurosets Srl
  • Fresenius Medical Care
  • Getinge AB
  • LivaNova Plc
  • Medos Medizintechnik AG
  • Medtronic Plc
  • Qura Srl
  • Senko Medical Instrument Mfg. Co., Ltd.
  • Terumo Corporation
Product Code: MRR-C27187914397

The Centrifugal Blood Pumps Market was valued at USD 93.02 million in 2025 and is projected to grow to USD 104.27 million in 2026, with a CAGR of 7.71%, reaching USD 156.46 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 93.02 million
Estimated Year [2026] USD 104.27 million
Forecast Year [2032] USD 156.46 million
CAGR (%) 7.71%

A concise foundational overview explaining centrifugal blood pump core technologies clinical roles and the performance attributes that drive procurement decisions

Centrifugal blood pumps have become foundational components across acute cardiac care pathways, offering a blend of hemodynamic support, compact footprints, and compatibility with advanced extracorporeal circulatory systems. This introduction defines the technological underpinnings of contemporary centrifugal designs, emphasizing hydrodynamic, magnetic levitation, and mechanical bearing architectures and how these approaches affect flow characteristics, hemocompatibility, and device longevity. It also frames the clinical applications where these pumps are most consequential, including perioperative cardiac surgery support, prolonged extracorporeal membrane oxygenation (ECMO) therapy, and short- to long-term ventricular assist device (VAD) applications.

Clinical demands, device miniaturization, and evolving regulatory expectations have collectively reshaped design priorities. As a result, stakeholders must reconcile competing objectives: minimizing shear stress and thrombogenicity while maintaining reliable flow delivery across a spectrum of patient sizes and pathophysiologies. This section outlines the primary performance attributes clinicians and procurement teams evaluate: flow stability at high, medium, and low rates; bearing and rotor technology trade-offs; and material selection between metallic and polymeric components. By clarifying these core concepts up front, the report prepares readers to interpret downstream sections on market dynamics, segmentation insights, and strategic recommendations.

How regulatory tightening clinical demand and rapid technology advances are reshaping centrifugal blood pump development commercialization and clinical adoption

The centrifugal blood pump landscape is undergoing transformative shifts driven by converging forces in clinical practice, regulatory scrutiny, and technological innovation. Clinically, an aging patient population and expanded indications for mechanical circulatory and extracorporeal support have increased demand for devices that balance efficacy with safety. Regulatory authorities have concurrently tightened post-market surveillance and device validation expectations, prompting manufacturers to invest more in durability testing, hemocompatibility studies, and real-world evidence programs. These regulatory shifts accelerate transitions from legacy mechanical-bearing designs toward magnetic levitation and advanced hydrodynamic systems that can demonstrably reduce blood trauma and maintenance burdens.

Technological innovation is equally pivotal. Advances in computational fluid dynamics, sensor integration, and closed-loop control systems enhance pump responsiveness and reduce clinician workload. Materials science developments provide new polymer formulations and coatings designed to resist protein adhesion and thrombus formation, while additive manufacturing enables bespoke components and reduced time-to-prototype. As stakeholders adopt remote monitoring and telemetric diagnostics, pumps increasingly function as nodes within broader care ecosystems, enabling earlier detection of adverse trends and facilitating outpatient management strategies that were previously infeasible. Taken together, these shifts create a landscape where strategic differentiation is rooted in demonstrable clinical outcomes, integrated digital capabilities, and a robust evidence base.

The 2025 tariff environment forcing supply chain realignment supplier localization and procurement strategies to protect clinical continuity and cost stability

The introduction of new tariff measures in 2025 has complicated cross-border supply chains and procurement strategies for medical device stakeholders, particularly those that rely on international sourcing of components or finished products. Tariff adjustments have elevated the cost base for manufacturers that import raw materials such as specialty metals, precision bearings, and polymer compounds, thereby incentivizing a reassessment of supplier relationships and cost-engineering approaches. In response, several manufacturers have accelerated supplier qualification programs, localized production where feasible, and restructured logistics to minimize the tariff impact on end users.

Importantly, the tariff environment has also shifted the calculus for tendering organizations and hospital procurement teams. Buyers are increasingly evaluating total landed cost and long-term service agreements rather than unit price alone. This shift has emphasized the value proposition of devices offering lower lifecycle maintenance, fewer consumable replacements, and extended warranties. Meanwhile, partnerships between device manufacturers and regional distributors are evolving to include flexible pricing models and consignment arrangements that mitigate near-term budgetary pressures. Overall, tariffs have catalyzed a series of operational responses that prioritize supply resilience, vertical integration, and contractual structures designed to protect clinical continuity amid pricing volatility.

Integrated segmentation intelligence revealing where clinical indications end-user profiles pump technologies flow regimes and material choices converge to shape procurement priorities

Segment-level insights reveal where clinical need and technological capability intersect most strongly. When assessing application-specific dynamics, cardiac surgery, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices emerge as distinct demand domains. ECMO subdivides into extracorporeal carbon dioxide removal, veno-arterial ECMO, and veno-venous ECMO, each with unique flow and durability requirements. Ventricular assist devices bifurcate into bi-ventricular, left ventricular, and right ventricular assist configurations, demanding tailored control strategies and bearing technologies.

End-user segmentation shows that ambulatory surgical centers, hospitals, and research institutes drive different procurement priorities. Within hospitals, cardiac specialty centers, general hospitals, and tertiary care hospitals exhibit divergent needs for device complexity, inventory depth, and on-site technical support. Pump type segmentation highlights the trade-offs between hydrodynamic bearing designs, magnetic levitation systems, and mechanical bearings, with each type offering distinct performance, maintenance, and hemocompatibility profiles. Flow-rate segmentation-high, medium, and low-further clarifies device suitability for acute versus chronic support and for adult versus pediatric applications. Material segmentation between metal and polymer components underscores considerations around weight, durability, manufacturability, and biocompatibility. Together, these segmentation lenses provide a composite view that helps clinicians and purchasers match technology attributes to clinical workflows and institutional capabilities.

Regional adoption patterns reimbursement realities and supply chain dynamics across the Americas Europe Middle East & Africa and Asia-Pacific shaping device uptake

Regional dynamics influence adoption patterns, reimbursement frameworks, and supply chain resilience across the centrifugal blood pump landscape. In the Americas, advanced tertiary centers and cardiac specialty hospitals drive early clinical adoption, supported by established reimbursement mechanisms and dense clinical networks that facilitate technology diffusion. These centers act as innovation hubs, generating real-world evidence and procedural protocols that propagate through regional referral systems. Conversely, cost containment pressures and procurement centralization mechanisms influence device selection in smaller hospitals and ambulatory centers.

Europe, Middle East & Africa presents a heterogeneous environment where regulatory harmonization efforts coexist with disparate procurement models. High-capability centers in western Europe often lead in clinical trials and post-market surveillance initiatives, while emerging markets in the region prioritize affordability and supply chain reliability. In Asia-Pacific, rapid hospital expansion, growing investment in critical care, and increasing local manufacturing capacity shape a competitive environment that emphasizes scalability and localization. Across all regions, strategic partnerships between manufacturers and regional distributors, as well as localized service capabilities, determine the ease of adoption and long-term device uptime.

Competitive dynamics spotlighting clinical evidence service networks and technology partnerships that differentiate incumbent manufacturers specialized firms and disruptive entrants

The competitive landscape is driven by a mix of established medical device firms, specialized manufacturers, and emerging technology entrants that focus on differentiated pump architectures and service models. Market leaders emphasize clinical evidence generation, extensive service networks, and integrated training programs for perfusionists and surgical teams. Mid-size players often compete on engineering flexibility and speed-to-market, leveraging modular designs and adaptable control systems to meet niche clinical requirements.

New entrants are frequently technology-centric, emphasizing magnetic levitation, compact hydrodynamic designs, or digital monitoring features that enable predictive maintenance. Across the spectrum, strategic partnerships between device manufacturers and component suppliers-particularly for precision bearings and hemocompatible materials-play a pivotal role in sustaining product reliability. Mergers, acquisitions, and licensing agreements remain common as companies seek to expand their clinical footprints, extend product portfolios, and secure technology advantages in sensor integration and telemetry. Service agreements, training offerings, and warranty structures increasingly differentiate vendors in procurement discussions.

Practical strategic actions for manufacturers providers and purchasers to enhance clinical outcomes secure supply resilience and create flexible commercial approaches

Industry leaders should prioritize initiatives that enhance clinical outcomes while stabilizing supply and cost structures. First, invest in robust clinical evidence programs that quantify hemocompatibility, device durability, and patient-centered outcomes across the primary application areas of cardiac surgery, ECMO subtypes, and VAD configurations. Demonstrable clinical benefit remains the most persuasive argument for adoption and reimbursement alignment. Second, strengthen supplier diversification and nearshoring strategies to reduce exposure to tariff-driven cost volatility while maintaining quality assurance for critical metallic and polymer components.

Third, expand service and training ecosystems to ensure consistent device performance across ambulatory centers, general hospitals, cardiac specialty centers, and tertiary institutions. This includes remote monitoring capabilities and predictive maintenance programs tied to telemetry and analytics. Fourth, accelerate material and bearing innovation by prioritizing low-shear rotor profiles, hemocompatible coatings, and validated polymer alternatives where appropriate. Finally, pursue flexible commercial models-such as outcome-linked payments, extended warranties, and consignment arrangements-to lower adoption barriers for budget-constrained institutions and to align long-term incentives between suppliers and healthcare providers.

A transparent mixed-methods research framework combining primary clinician stakeholder interviews technical evaluation and supply chain analysis to underpin conclusions

This research synthesizes multiple evidence streams to provide a robust analytical foundation. Primary data collection included structured interviews with clinicians, perfusionists, procurement professionals, and manufacturing engineers across diverse hospital settings and regional markets. These conversations informed qualitative assessments of clinical workflows, device integration challenges, and service requirements. Secondary research encompassed peer-reviewed literature on hemocompatibility, regulatory guidance documents, technical whitepapers on bearing technologies and materials science, and product-specific technical specifications to validate performance claims.

Analytical methods combined thematic synthesis of qualitative insights with comparative technical evaluation of pump architectures. Supply chain analyses assessed component sourcing pathways, logistics configurations, and tariff impacts. Regional adoption patterns were examined through a cross-sectional review of healthcare infrastructure indicators and hospital capacity trends. Throughout, the methodology emphasized transparency in source triangulation and critical appraisal of vendor-provided claims. Where applicable, sensitivity testing and scenario analysis clarified how shifts in tariffs, regulatory expectations, or clinical practice patterns could influence operational strategies without relying on proprietary numeric projections.

Closing synthesis emphasizing the interplay between clinical validation supply resilience and service excellence that will determine long-term device adoption

In conclusion, centrifugal blood pumps are positioned at the intersection of clinical necessity and engineering innovation. Contemporary trends favor designs that prioritize hemocompatibility, responsive control systems, and lower lifecycle burdens, while regulatory and tariff pressures are prompting manufacturers to rethink supply chains and evidence-generation strategies. End users-from ambulatory surgical centers to tertiary care hospitals-require solutions that align with local clinical workflows, staffing levels, and total operational demands, making service capability and training as important as device performance.

Looking ahead, stakeholders that combine rigorous clinical validation with resilient production strategies and adaptable commercial models will be best placed to meet evolving institutional priorities. Device developers that invest in material science, bearing technology, and integrated monitoring will create tangible differentiation, and purchasers that emphasize total cost of ownership and service continuity will better safeguard patient outcomes. This balance of clinical evidence, operational resilience, and user-centric support will determine which technologies achieve sustained adoption across diverse healthcare settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Centrifugal Blood Pumps Market, by Pump Type

  • 8.1. Hydrodynamic Bearing
  • 8.2. Magnetic Levitation
  • 8.3. Mechanical Bearing

9. Centrifugal Blood Pumps Market, by Flow Rate

  • 9.1. High Flow
  • 9.2. Low Flow
  • 9.3. Medium Flow

10. Centrifugal Blood Pumps Market, by Material

  • 10.1. Metal
  • 10.2. Polymer

11. Centrifugal Blood Pumps Market, by Application

  • 11.1. Cardiac Surgery
  • 11.2. Extra Corporeal Membrane Oxygenation
    • 11.2.1. Extra Corporeal CO2 Removal
    • 11.2.2. Veno Arterial ECMO
    • 11.2.3. Veno Venous ECMO
  • 11.3. Ventricular Assist Devices
    • 11.3.1. Bi Ventricular Assist Devices
    • 11.3.2. Left Ventricular Assist Devices
    • 11.3.3. Right Ventricular Assist Devices

12. Centrifugal Blood Pumps Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
    • 12.2.1. Cardiac Specialty Centers
    • 12.2.2. General Hospitals
    • 12.2.3. Tertiary Care Hospitals
  • 12.3. Research Institutes

13. Centrifugal Blood Pumps Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Centrifugal Blood Pumps Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Centrifugal Blood Pumps Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Centrifugal Blood Pumps Market

17. China Centrifugal Blood Pumps Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Artimedica
  • 18.7. Baxter International Inc.
  • 18.8. Berlin Heart GmbH
  • 18.9. BiVACOR Inc.
  • 18.10. Braile Biomedica Ltd.
  • 18.11. Eurosets S.r.l.
  • 18.12. Fresenius Medical Care
  • 18.13. Getinge AB
  • 18.14. LivaNova Plc
  • 18.15. Medos Medizintechnik AG
  • 18.16. Medtronic Plc
  • 18.17. Qura Srl
  • 18.18. Senko Medical Instrument Mfg. Co., Ltd.
  • 18.19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HYDRODYNAMIC BEARING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HYDRODYNAMIC BEARING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HYDRODYNAMIC BEARING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MAGNETIC LEVITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MAGNETIC LEVITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MAGNETIC LEVITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MECHANICAL BEARING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MECHANICAL BEARING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MECHANICAL BEARING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HIGH FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HIGH FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HIGH FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LOW FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LOW FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LOW FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MEDIUM FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MEDIUM FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MEDIUM FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL CO2 REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL CO2 REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL CO2 REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO ARTERIAL ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO ARTERIAL ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO ARTERIAL ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO VENOUS ECMO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO VENOUS ECMO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENO VENOUS ECMO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY BI VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY BI VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY BI VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY CARDIAC SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY PUMP TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY FLOW RATE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY EXTRA CORPOREAL MEMBRANE OXYGENATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CENTRIFUGAL BLOOD PUMPS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)